| Mrs Lindsay Nicole Price, LMFT | |
|
2600 N Mayfair Rd Ste 650, Wauwatosa, WI 53226-1322 | |
| (414) 771-9304 | |
| Not Available |
| Full Name | Mrs Lindsay Nicole Price |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 2600 N Mayfair Rd Ste 650, Wauwatosa, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275182511 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 1255-124 (Wisconsin) | Primary |
| Entity Name | Shore Counseling And Consulting Clinic Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588710073 PECOS PAC ID: 3072580547 Enrollment ID: O20040914000637 |
News Archive
University of Pennsylvania scientists studying macrophages, the biological cells that spring from white blood cells to eat and destroy foreign or dying cells, have discovered how these "policemen" differentiate between friend and foe.
Because of the growing waistlines of many American bus passengers, the U.S. government may have to rewrite bus safety rules. The Federal Transit Authority (FTA) wants to raise the assumed average weight per bus passenger from 150 pounds to 175 pounds and add an extra quarter of a square foot of floor space per passenger. The agency says the proposals "acknowledge the expanding girth of the average passenger."
The uproar that began last year when the U.S. Preventive Services Task Force stated that doctors should no longer offer regular prostate-cancer tests to healthy men continued this week when the task force released their final report. Overall, they stuck to their guns, stating that a blood test commonly used to screen for prostate cancer, the PSA test, causes more harm than good - it leads men to receive unnecessary, and sometimes even dangerous, treatments.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today stated that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lindsay Nicole Price, LMFT 2600 N Mayfair Rd Ste 650, Wauwatosa, WI 53226-1322 Ph: (414) 771-9304 | Mrs Lindsay Nicole Price, LMFT 2600 N Mayfair Rd Ste 650, Wauwatosa, WI 53226-1322 Ph: (414) 771-9304 |
News Archive
University of Pennsylvania scientists studying macrophages, the biological cells that spring from white blood cells to eat and destroy foreign or dying cells, have discovered how these "policemen" differentiate between friend and foe.
Because of the growing waistlines of many American bus passengers, the U.S. government may have to rewrite bus safety rules. The Federal Transit Authority (FTA) wants to raise the assumed average weight per bus passenger from 150 pounds to 175 pounds and add an extra quarter of a square foot of floor space per passenger. The agency says the proposals "acknowledge the expanding girth of the average passenger."
The uproar that began last year when the U.S. Preventive Services Task Force stated that doctors should no longer offer regular prostate-cancer tests to healthy men continued this week when the task force released their final report. Overall, they stuck to their guns, stating that a blood test commonly used to screen for prostate cancer, the PSA test, causes more harm than good - it leads men to receive unnecessary, and sometimes even dangerous, treatments.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today stated that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
› Verified 1 days ago
Mrs. Caroline Burnett, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 8651 W North Ave, Wauwatosa, WI 53226 Phone: 414-774-9200 | |
Ms. Rachael Goldmann, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1220 Dewey Ave, Wauwatosa, WI 53213 Phone: 414-773-4312 | |
Brooke S Siddell, Couples Therapy Medicare: Medicare Enrolled Practice Location: 3800 N Mayfair Rd, Wauwatosa, WI 53222 Phone: 414-536-8333 Fax: 414-536-8348 | |
Larry E Mc Dowell, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1220 Dewey Ave, Dewey Center, Wauwatosa, WI 53213 Phone: 414-454-6707 Fax: 414-454-6747 | |
Neaokia Collins, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 10045 W Lisbon Ave, Wauwatosa, WI 53222 Phone: 414-358-7999 | |
Sara Renee James, M.S., LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 1220 Dewey Ave, Wauwatosa, WI 53213 Phone: 414-454-6500 Fax: 414-454-6522 |